Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Helicobacter pylori eradication for functional dyspepsia
IRCT20140519017756N37Phase 2Completed
- Sponsor
- Vice Chancellor for Research, Birjand University of Medical Sciences
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of clarithromycin, amoxicillin, bismuth subsalicylate and omeprazole in functional dyspepsia (FD) and Helicobacter pylori infection (2 arms), sponsored by Vice Chancellor for Research, Birjand University of Medical Sciences. Primary endpoints: Response to treatment and Complications. Started Mar 2015; status: completed.
02
Drugs
clarithromycinamoxicillinbismuth subsalicylateomeprazole
03
Conditions
functional dyspepsia (FD)Helicobacter pylori infection
Beyond the preview
Go deeper on IRCT20140519017756N37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140519017756N37.